NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001025

Registered date:15/02/2008

Phase I study of preoperative Docetaxel, Cisplatin and S-1 for patients with advanced gastric cancer

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedPatients with unresectable gastric cancer due to limited invasion and/or metastasis.
Date of first enrollment2007/10/01
Target sample size24
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Docetaxel day 1, 15 Cisplatin dat 1, 15 S-1 80mg/m2 day 1-14 every 28 days for 2 cycles followed by gastrectomy

Outcome(s)

Primary OutcomeSafety
Secondary OutcomeAdverse events Ratio of complete treatment Response rate of preoperative chemotherapy

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteria1. Active infection 2. Other severe complications 3. Active double cancer 4. CNS metastasis 5. Pericardiac fluid 6. Mortor paralysis or peripheral neural disturbance. 7. History of severe allergy against drug. 8. Severe peritoneal metastasis 9. Pregnant women or women who like to be pregnant. 10. Doctor' s dicision not to be registered to this study.

Related Information

Contact

public contact
Name Sachio Fushida
Address Takara-machi 13-1, Kanazawa Japan
Telephone 076-265-2362
E-mail
Affiliation Kanazawa University Hospital Gastroenterologic Surgery
scientific contact
Name Takashi Fujimura
Address Takara-machi 13-1, Kanazawa Japan
Telephone 076-265-2362
E-mail
Affiliation Kanazawa University Hospital Gastroenterologic Surgery